0001358403-15-000033.txt : 20150619
0001358403-15-000033.hdr.sgml : 20150619
20150619170608
ACCESSION NUMBER: 0001358403-15-000033
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150616
FILED AS OF DATE: 20150619
DATE AS OF CHANGE: 20150619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Spencer David M.
CENTRAL INDEX KEY: 0001627362
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 15943026
MAIL ADDRESS:
STREET 1: C/O BELLICUM PHARMACEUTICALS, INC.
STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
4/A
1
wf-form4a_143474795838162.xml
FORM 4/A
X0306
4/A
2015-06-16
2015-06-18
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001627362
Spencer David M.
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
Chief Scientific Officer
Common Stock
2015-06-16
4
S
0
17200
22.8227
D
166400
D
Common Stock
2015-06-16
4
S
0
2800
23.7939
D
163600
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 23, 2015.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.52 to $23.51. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Includes 846 shares acquired under the Issuer's Employee Stock Purchase Plan on June 10, 2015. These shares were inadvertently omitted from the Reporting Person's original Form 4 filed with the SEC on June 18, 2015
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.52 to $24.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/ Ken Moseley, Attorney-in-Fact
2015-06-19